New Strategies for the Treatment of Pulmonary Hypertension in Sickle Cell Disease: The Rationale for Arginine Therapy

By Morris Claudia R.  

Treatments in Respiratory Medicine, Vol. 5, Iss. 1, 2006-01 ,pp. : 31-45

Adis International

Access to resources Recommend Favorite

Hemolysis-Associated Pulmonary Hypertension in Sickle Cell Disease: Global Disruption of the Arginine-Nitric Oxide Pathway

By  

Current Hypertension Reviews, Vol. 3, Iss. 3, 2007-08 ,pp. : 223-230

Bentham Science Publishers

Access to resources Recommend Favorite

What's New in the Pathophysiology of Sickle Cell Disease?

By  

Medical Principles and Practice, Vol. 22, Iss. 4, 2013-04 ,pp. : 311-312

Karger

Access to resources Recommend Favorite

High Prevalence of Pulmonary Hypertension in Homozygous Sickle Cell Patients with Leg Ulceration

By Serarslan Gamze   Akgul Ferit   Babayigit Cenk  

Clinical and Experimental Hypertension, Vol. 31, Iss. 1, 2009-02 ,pp. : 44-48

Informa Healthcare

Access to resources Recommend Favorite

Safety And Efficacy Of 4 Years Of Deferasirox Treatment For Sickle Cell Disease Patients

By Vlachaki Efthymia  

Hemoglobin, Vol. 37, Iss. 1, 2013-02 ,pp. : 94-100

Informa Healthcare

Access to resources Recommend Favorite